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Figure 1 | Comparison of various urinary biomarkers in cross-
sectional study. Combined box and whisker and dot plot of
normalized urinary MMP-9, NAG, and KIM-1 levels is shown
among control (non-AKI), AKI, and UTI groups. AKI, acute kidney





























































































Figure 3 | Pattern of urinary biomarker expression in
case–control study. Graphs showing mean normalized urine
KIM-1, NAG, and MMP-9 concentrations at multiple time points
after cardiopulmonary bypass. Error bars are s.e.








AKI (n=29) 3.3 (2.1–5.5)*, ^ 53.6 (20.0–93.5)*, ** 3.9 (0.2–14.9)*
Control (n=45) 0.1 (0.1–0.2) 2.7 (2.3–3.8) 0.0 (0.0–0.3)
Normal (n=30) 0.1 (0.0–0.2) 2.3 (1.9–3.4) 0.0 (0.0–0.7)
CKD (n=15) 0.1 (0.1–0.4) 4.7 (2.4–7.0) 0.0 (0.0–1.3)
UTI (n=10) 0.4 (0.2–2.0) 4.1 (2.2–11.4) 66.9 (11.3–203.3)*, ^^
AKI, acute kidney injury; CKD, chronic kidney disease; KIM-1, kidney injury molecule-1; MMP-9, matrix metalloproteinase-9; NAG, N-acetyl-b-D-glucosaminidase; Ucr, urine
creatinine; UTI, urinary tract infection.
Values are medians (95% CI for median).
*Po0.001 vs control; **Po0.001 vs UTI; ^P=0.002 vs UTI; ^^Po0.001 vs AKI.
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Table 4 | Comparison of various urinary marker levels in patients with AKI and non-AKI
Post-Op
Pre-Op 2 h 6 h 12 h 24 h 36 h 48 h
Normalized value
KIM-1 (ng mg1 Ucr) * * * *
AKI 0.2 (0.0–1.2) 0.6 (0.0–2.3) 0.7 (0.2–2.7) 3.6 (1.8–18.0) 4.6 (1.2–14.9) 4.0 (1.9–14.5) 4.7 (3.2–10.8)
Non-AKI 0.4 (0.0–1.9) 1.1 (0.0–3.9) 1.4 (0.2–2.6) 0.4 (0.0–1.6) 0.5 (0.0–1.6) 0.6 (0.0–2.3) 0.9 (0.1–3.1)
NAG (U g1 Ucr) ** ** **
AKI 17.6 (5.5–52.9) 21.1 (8.6–54.8) 32.0 (10.0–70.9) 78.1 (46.7–255.2) 74.1 (47.2–241.8) 79.1 (53.5–186.9) 80.9 (46.3–128.5)
Non-AKI 28.6 (15.0–59.5) 32.1 (18.3–64.6) 31.9 (21.3–122.0) 39.7 (22.7–117.0) 38.6 (19.3–71.0) 38.1 (15.0–88.9) 44.8 (14.6–87.7)
MMP-9 (ng mg1 Ucr)
AKI ND ND ND ND ND ND ND
Non-AKI ND ND ND ND ND ND ND
AKI, acute kidney injury; ND, non-detectable; Ucr, urine creatinine.
Values are medians (95% CI for median).
*Po0.005 vs non-AKI; **Po0.05 vs non-AKI.
Table 6 | Performance of urinary KIM-1 and NAG for diagnosis of AKI at various time points in case–control study
Sensitivity Specificity Positive likelihood ratio Negative likelihood ratio
Urinary KIM-1 at 6 h
42.0 ng mg1 Ucr 65 42 1.12 0.83
47.0 ng mg1 Ucr 85 21 1.08 0.71
418.0 ng mg1 Ucr 90 16 1.07 0.63
Urinary KIM-1 at 12 h
42.0 ng mg1 Ucr 74 90 7.37 0.29
47.0 ng mg1 Ucr 32 90 3.16 0.76
418.0 ng mg1 Ucr 21 90 2.11 0.88
Urinary KIM-1 at 24 h
42.0 ng mg1 Ucr 65 80 3.25 0.44
47.0 ng mg1 Ucr 35 90 3.50 0.72
418.0 ng mg1 Ucr 20 90 2.00 0.89
Urinary NAG at 6 h
410.0 U g1 Ucr 25 84 1.58 0.89
425.0 U g1 Ucr 50 63 1.36 0.79
440.0 U g1 Ucr 55 37 0.87 1.22
Urinary NAG at 12 h
410.0 U g1 Ucr 100 10 1.11 0.00
425.0 U g1 Ucr 100 30 1.43 0.00
440.0 U g1 Ucr 84 55 1.87 0.29
Urinary NAG at 24 h
410.0 U g1 Ucr 95 20 1.19 0.25
425.0 U g1 Ucr 85 25 1.13 0.60
440.0 U g1 Ucr 80 55 1.78 0.36
AKI, acute kidney injury; KIM-1, kidney injury molecule-1; NAG, N-acetyl-b-D-glucosaminidase; Ucr, urine creatinine.
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